反応式
CC(C)(C)OC(N)=O.COC(=O)c1ncc(Br)cn1>C1COCCO1.CC(=O)O.CC(=O)O.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C([O-])[O-].[Cs+].[Cs+].[Pd]>COC(=O)c1ncc(NC(=O)OC(C)(C)C)cn1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 90 °C
実験手順
The methyl 5-bromopyrimidine-2-carboxylate (4 g, 18.43 mmol), tert-butyl carbamate (3.02 g, 25.80 mmol), diacetoxypalladium (0.207 g, 0.92 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (1.066 g, 1.84 mmol), cesium carbonate (9.01 g, 27.65 mmol) and dioxane (50 mL) were placed and sealed into a microwave tube. The reaction was degased, purged with argon and heated to 90 °C (oil bath) over a period of 7 hours . The mixture was poured in water, extracted with ethyl acetate (x2). The organic phase was washed with brine, dried over magnesium sulfate and concentrated. The crude product was purified by flash chromatography on silica gel 15-40µm eluting with 5 to 50% ethyl acetate in dichloromethane. The solvent was evaporated to dryness to afford methyl 5-(tert- butoxycarbonylamino)pyrimidine-2-carboxylate (3.00 g, 64.3 %) as a beige solid.
出典と根拠
- ORDレコード
- ord-f833eea6508044b8abf8f02c39f87010
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…